FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/19/2025
Back to search
Official data from USPTO
ACCROPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACCROPEUTICS
ST13
US500000079374058Class
5, 42
Filing
79374058
Registration
7546743
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 42
Filing date
05/06/2023
Registration date
10/29/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/29/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
CN
Examiner
VELTEN, MALLORY KATE
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Accro Bioscience(Suzhou) Limited
Representatives
Eric Lamb Frost Brown Todd LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of inflammatory diseasesautoimmune diseasescancerneurodegenerative diseasescardiovascular diseasesinfectious diseases; Biological preparations for the prevention and treatment of inflammatory diseasesautoimmune diseasescancerneurodegenerative diseasescardiovascular diseasesinfectious diseases; chemical reagents for medical or veterinary purposes; medicinal preparations for the prevention and treatment of inflammatory diseasesautoimmune diseasescancerneurodegenerative diseasescardiovascular diseasesinfectious diseases; preparations of microorganisms for medical purposes; chemical preparations for pharmaceutical purposesfor the prevention and treatment of inflammatory diseasesautoimmune diseasescancerneurodegenerative diseasescardiovascular diseasesinfectious diseases; veterinary pharmaceutical preparations for the prevention and treatment of infectious diseases; medicines for veterinary purposesveterinary pharmaceutical preparations for the prevention and treatment of infectious diseases
Class 42
Research and development of new products for others; technological research in the field of medicine and medical instruments; chemical analysis; chemistry consultation; chemical research; medical research; scientific research in the nature of conducting clinical trials for others; biological research; bacteriological research; cloud computing featuring software for accessingreadingtracking information in the field of medicine and medical devices
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/31/2025
FIMP
FINAL DISPOSITION PROCESSED
03/31/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/29/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/04/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/16/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/13/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/29/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2024
PUBO
PUBLISHED FOR OPPOSITION
08/13/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
07/03/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/03/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
07/03/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/28/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/28/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/28/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/28/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/28/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/28/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/28/2024
RFNT
REFUSAL PROCESSED BY IB
03/18/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/28/2024
RFRR
REFUSAL PROCESSED BY MPU
02/28/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/07/2024
CNRT
NON-FINAL ACTION WRITTEN
02/06/2024
DOCK
ASSIGNED TO EXAMINER
01/31/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/14/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/13/2023
Continuous trademark protection
Get notified about every new filing that threatens ACCROPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.